Talisman Energy, Inc. TLM
We began tracking TLM on Friday after noticing the stock coming up off of its recently-registered 52-week low, and on that day we observed a low of 4.17.
The stock made higher highs and higher lows yesterday following another inclusion in our morning report, making definite progress, but with a surprise buyout announcement early this morning the PPS has gone into overdrive. The all-cash transaction is valued at $8 Billion, and has been unanimously approved on all sides.
CALGARY, ALBERTA–(Marketwired – Dec 16, 2014) – Talisman Energy Inc. (TLM.TO)(TLM) is pleased to announce that it has entered into a definitive agreement (the “Arrangement Agreement”) with Repsol S.A. under which Repsol will acquire all of the outstanding common shares of Talisman for US$8.00 (C$9.33) per share in cash. >> FULL PR
The premarket high thus far today stands at 7.74, which marks an increase of 85% that we’ve witnessed in TLM over the course of just a few days. Congrats to anyone who caught our pre-emptive alert and was able to take advantage!
China HGS Real Estate, Inc. HGSH
Another winning call off of yesterday’s report was HGSH; the stock appeared in our extended watchlist, and went on to have quite a fruitful session. The stock would open and briefly touch a low of 4.63 before spending the rest of the day on the rise, culminating in an afternoon high of 5.96.
That solid intraday move came on more than 10 the 3-month average volume, and represented a highly respectable increase of 29%
Frontline Ltd. FRO
Despite seeing a gap-down in this morning’s pre-market on the heels of a debt-for-equity program announced by FRO, we did see a nice move out of the stock yesterday after including it in our last couple of newsletters. It made an intraday move from 2.53 to 2.95 (+17%).
We observed a low of 1.88 on Friday, meaning that yesterday’s high figured in as a two-day overall increase of 57%
BioLineRx Ltd. BLRX
BLRX also appeared in yesterday’s extended watchlist, and while it had a tough time getting going yesterday, the stock is up significantly in today’s premarket activity on the strength of a new PR so we’ll be sure to monitor the situation as the week progresses.
The company has signed an agreement with pharma-giant Novartis, under which Novartis has made an initial equity investment in BLRX of $10M for 12.8% of BLRX’s current shares outstanding. Read more about it in the following news announcement:
- BioLineRx and Major Global Pharmaceutical Company Form Strategic Collaboration for Screening and Development of Novel Drug Candidates (Tue 7:00AM EST)
Extended Watchlist:
PHMD, AUY, GERN, RAD, JNUG